The inhibition ofthe PD-1/PD-L1 pathway with anti-PD-1 and antiPD-L1 antibodies reduces sepsis-induced apoptosis inlymphocytes and returns the ability of immune cells toproduce proinflammatory cytokines (20, 21). The gene discussed is PDCD1; the disease is Sepsis.